People With Osteoporosis Can Walk-BEST to Reduce Fall and Fracture Risk

What this study is about

The aim of the Walk BEST study is to provide evidence that it is feasible to implement the technology assisted gait- focused walking program Walk-BEST™ in older adults with osteoporosis, and that this program is acceptable to this population.

Who can join (things the study team will check)

✅ You may be able to join if…

• men and women 70 years and older
• able to walk independently with or without a walking aid
• experienced a prior fracture after the age of 40, OR two falls in the past 12 months, OR who have a bone mineral density test (done as part of routine clinical evaluation) with a T-score < -2.5, OR on a Health Canada-approved anti-osteoporosis medication (oral or intravenous bisphosphonate, denosumab, teriparatide, or romozosumab) to reduce fracture risk or on a bisphosphonate drug holiday (planned treatment interruption)

🚫 You may not be able to join if…

• fracture sustained in the past 12 months
• unable to walk unsupervised because of active medical or neurocognitive reasons
• unable to provide informed consent, or cannot communicate in English or French

Where this trial is running

• Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada

Who to contact

Velizara Garkova, MSc · 514-934-1934 · velizara.garkova@rimuhc.ca

It's completely normal to call and ask questions before deciding anything. Mention the study ID: NCT07621679.